OptiMesh®

Conforms to You

The only conforming, patient specific expandable implant on the market, OptiMesh is delivered through one of the smallest insertion profiles, dynamically conforms to a patient’s unique endplate morphology, and powerfully expands to one of the largest implant footprints available.*

OptiMesh, featuring Conform and Expand technology, is designed to provide a custom anatomical fit for lumbar fusion surgical patients.

Natural Restoration and Expansion Power

OptiMesh’s powerful distraction forces and conformance to the endplates provide strength and stability to restore disc height, achieve alignment goals, and promote a robust fusion.1

Efficient Delivery of Biologics

With nearly the entire implant comprised of biologics, OptiMesh offers a comprehensive fusion scaffold and provides one of the most efficient ways to deliver biologics to the spine. Backed with IDE level data, this is an implant category of its own.

Effecient Delivery of Biologics

OptiMesh

Unparalleled Versatility

Open

TLIF/PLIF

MIS

TLIF

Ultra-MIS

OptiLIF®

Ultra-MIS

OptiLIF® Endo

A single implant may be used for multiple lumbar fusion approaches accommodating patient specific needs. No matter your approach to lumbar fusion, OptiMesh provides a best in class expandable interbody solution from Open, MIS TLIF, ultra-MIS (OptiLIF), to endoscopic fusion (OptiLIF Endo) applications.

OptiMesh OptiLIF Procedure

Ultra-Minimally Invasive Delivery, Maximal Patient Outcomes

OptiMesh’s ultra-minimally invasive delivery is designed to provide patients with the benefits of MIS surgery through a reproducible, efficient procedure, without sacrificing, but maximizing footprint coverage. Published clinical results show improved patient outcomes, such as:

  • Shorter hospital stays1
  • Higher post-operative patient satisfaction2
  • Faster return to work2
  • Reduced use of narcotics over time2

[1] Lavoie S, Bydon M, Nunley P, Sandhu F, Shore J, Stone M. Does indirect decompression vs open decompression in percutaneous interbody fusion provide better results? An ad-hoc analysis of a prospective multi-center percutaneous interbody fusion study. International Society for the Advancement of Spine Surgery (ISASS) Annual Conference 2021. Miami, FL. 2021 May 13-15.

[2] Chi J, Nunley P, et al. Two-Year Outcomes From a Prospective Multicenter Investigation Device Trial of a Novel Conformal Mesh Interbody Fusion Device. Int J Spine Surg. 2021 Dec; 15(6): 1103-1114.

* Data on file

Unmatched Clinical Experience

The SCOUT IDE Study

Unique in design and in published data, OptiMesh holds the highest achievement in clinical validation with an IDE De Novo level grant. Spineology Clinical Outcomes Trial (SCOUT Study): IDE trial of a novel, conformable device placed in the disc space through a small portal and filled with bone graft in-situ. At 24 months:

  • 92% patients rated satisfaction as excellent/good
  • Mean ODI improved 32.0 ± 18.5
  • 90% (95/96) fusion

0%

98% fusion at 12 months post-op, evaluated by two independent radiologists.

0%

Patients experienced on average, a 67% reduction in back pain at 3 months.

0%

51% of patients on average experienced an improvement in back function by month 3 post-op.

0%

92% of patients rated their satisfaction "excellent" or "good" at 6 months.

There were no device-related serious adverse events.

Chi J, Nunley P, et al. Two-Year Outcomes From a Prospective Multicenter Investigation Device Trial of a Novel Conformal Mesh Interbody Fusion Device. Int J Spine Surg. 2021 Dec; 15(6): 1103-1114.

Whitepapers@4x

Unique in Data

20 Clinical Publications

> 50,000 implants

Additionally, 20+ years of clinical experience, 20 clinical publications, and > 50,000 devices implanted set OptiMesh alone in the interbody fusion space.

A Game Changer

Samuel A. Joseph, Jr MD

"This is a revolutionary technique that helps patients get back to their lives incredibly fast. There is nothing out there as effective and powerful as Spineology’s OptiMesh."

Founder  & CEO of Joseph Spine Institute

Medical Director of Spine Surgery, South Tampa Hospital

Tampa Bay Buccaneers Team Spine Surgeon

Betsy H. Grunch, MD, FAANS, FACS, Neurosurgery

Betsy H. Grunch, MD, FAANS, FACS, Neurosurgery

The Longstreet Clinic, GA

“Learning this approach and implant was one of the simplest procedures compared to an anterior or lateral approach. It is a very simple approach that is very consistent and can give you optimal results every single time.”